Yosipovitch G, Lio PA, Rosmarin D, Legat FJ, et al. Lebrikizumab Improved Itch Symptoms and Reduced Itch Interference on Sleep Over 52 Weeks in Patients with Moderate-to-Severe Atopic Dermatitis in Two Phase 3 Trials. Dermatology 2025 Jul 2:1-19. doi: 10.1159/000547142.
PMID: 40602386